125 related articles for article (PubMed ID: 2121332)
1. Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy.
Koutcher JA; Alfieri AA; Kornblith AB; Devitt ML; Cowburn D; Ballon D; Kim JH
Cancer Res; 1990 Nov; 50(22):7252-6. PubMed ID: 2121332
[TBL] [Abstract][Full Text] [Related]
2. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
[TBL] [Abstract][Full Text] [Related]
3. Changes in 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors.
Koutcher JA; Alfieri AA; Barnett DC; Cowburn DC; Kornblith AB; Kim JH
Radiat Res; 1990 Mar; 121(3):312-9. PubMed ID: 2315448
[TBL] [Abstract][Full Text] [Related]
4. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
5. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
[TBL] [Abstract][Full Text] [Related]
6. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization of murine tumors by Fluosol-DA 20%.
Lee I; Levitt SH; Song CW
Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
[TBL] [Abstract][Full Text] [Related]
8. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
Martin DF; Porter EA; Fischer JJ; Rockwell S
Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
[TBL] [Abstract][Full Text] [Related]
9. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Teicher BA; Holden SA; Jacobs JL
Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
[TBL] [Abstract][Full Text] [Related]
10. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
Teicher BA; Holden SA
Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
[TBL] [Abstract][Full Text] [Related]
11. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
Teicher BA; Crawford JM; Holden SA; Cathcart KN
Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
[TBL] [Abstract][Full Text] [Related]
12. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
13. Effects of pentobarbital anesthesia on the energy metabolism of murine tumors studied by in vivo 31P nuclear magnetic resonance spectroscopy.
Okunieff P; Rummeny E; Vaupel P; Skates S; Willett C; Neuringer LJ; Suit HD
Radiat Res; 1988 Aug; 115(2):361-72. PubMed ID: 3406373
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
15. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
16. Correlation between radiosensitivity, percentage hypoxic cells and pO2 measurements in one rodent and two human tumor xenografts.
Thomas CD; Chavaudra N; Martin L; Guichard M
Radiat Res; 1994 Jul; 139(1):1-8. PubMed ID: 8016297
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.
Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA
Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854
[TBL] [Abstract][Full Text] [Related]
18. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.
Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ
Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001
[TBL] [Abstract][Full Text] [Related]
19. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
20. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
